Instructions for Authors
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 30, 2016 Category: Transplant Surgery Source Type: research
Previous Issue
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 30, 2016 Category: Transplant Surgery Source Type: research
Subscription Prices
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 11, 2016 Category: Transplant Surgery Source Type: research
Editorial Board
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 11, 2016 Category: Transplant Surgery Source Type: research
Table of Contents
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 11, 2016 Category: Transplant Surgery Source Type: research
Instructions for Authors
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 11, 2016 Category: Transplant Surgery Source Type: research
Previous Issue
(Source: Transplantation Reviews)
Source: Transplantation Reviews - June 11, 2016 Category: Transplant Surgery Source Type: research
Clinical value of non-HLA antibodies in kidney transplantation: Still an enigma?
HLA antibodies play a major role in the recipient's immune response against the renal allograft and are an established risk factor for antibody-mediated rejection and subsequent impaired graft survival. Evidence originating from HLA-identical donor –recipient pairs indicates that non-HLA antibodies may play a role as well. Numerous non-HLA antibodies have been identified in renal organ transplantation, directed against a heterogeneous subset of both allo- and autoantigens including MHC Class-I-related chain A (MICA) and Angiotensin II type 1 receptor (AT1R). (Source: Transplantation Reviews)
Source: Transplantation Reviews - June 6, 2016 Category: Transplant Surgery Authors: Laura A. Michielsen, Arjan D. van Zuilen, Merle M. Krebber, Marianne C. Verhaar, Henny G. Otten Source Type: research
Clinical value of non-HLA antibodies in kidney transplantation: still an enigma?
HLA antibodies play a major role in the recipient's immune response against the renal allograft and are an established risk factor for antibody-mediated rejection and subsequent impaired graft survival. Evidence originating from HLA-identical donor-recipient pairs indicates that non-HLA antibodies may play a role as well. Numerous non-HLA antibodies have been identified in renal organ transplantation, directed against a heterogeneous subset of both allo- and autoantigens including MHC Class-I-related chain A (MICA) and Angiotensin II type 1 receptor (AT1R). (Source: Transplantation Reviews)
Source: Transplantation Reviews - June 6, 2016 Category: Transplant Surgery Authors: Laura A. Michielsen, Arjan D. van Zuilen, Merle M. Krebber, Marianne C. Verhaar, Henny G. Otten Source Type: research
Computational immuno-biology for organ transplantation and regenerative medicine
Organ transplantation and regenerative medicine are adopted platforms that provide replacement tissues and organs from natural or engineered sources. Acceptance, tolerance and rejection depend greatly on the proper control of the immune response against graft antigens, motivating the development of immunological and genetical therapies that prevent organ failure. They rely on a complete, or partial, understanding of the immune system. Ultimately, they are innovative technologies that ensure permanent graft tolerance and indefinite graft survival through the modulation of the immune system. (Source: Transplantation Reviews)
Source: Transplantation Reviews - May 26, 2016 Category: Transplant Surgery Authors: Gustavo A. V ásquez-Montoya, Juan S. Danobeitia, Luis A. Fernández, Juan P. Hernández-Ortiz Source Type: research
Immunosuppression in the elderly renal allograft recipient: a systematic review
The Elderly are the fastest growing part of kidney transplant recipients. The best immunosuppressive strategy is unknown. (Source: Transplantation Reviews)
Source: Transplantation Reviews - May 19, 2016 Category: Transplant Surgery Authors: Nuria Montero, Mar ía José Pérez-Sáez, Julio Pascual, on behalf of the DESCARTES Working Group, DESCARTES ERA-EDTA Board:, Daniel Abramowicz, Klemens Budde, Chris Dudley, Mark Hazzan, Marian Klinger, Umberto Maggiore, Rainer Oberbauer, Julio Pascual, Source Type: research
Immunosuppression in the elderly renal allograft recipient: a systematic review
Elderly are the fastest growing part of kidney transplant recipients. The best immunosuppressive strategy is unknown. (Source: Transplantation Reviews)
Source: Transplantation Reviews - May 19, 2016 Category: Transplant Surgery Authors: Nuria Montero, María José Pérez-Sáez, Julio Pascual, DESCARTES Working Group, DESCARTES ERA-EDTA Working Group, Daniel Abramowicz, Klemens Budde, Chris Dudley, Mark Hazzan, Marian Klinger, Umberto Maggiore, Rainer Oberbauer, Julio Pascual, Soren S. So Source Type: research
Ex-vivo liver perfusion for organ preservation: Recent advances in the field
Liver transplantation is the optimal treatment for end-stage liver disease but is limited by the severe shortage of donor organs. This shortage has prompted increased utilization of marginal grafts from DCD and extended criteria donors, which poorly tolerate cold storage in comparison to standard criteria grafts. Ex-vivo liver perfusion (EVLP) technology has emerged as a potential alternative to cold storage for organ preservation, but there is no consensus regarding the optimal temperature or conditions for EVLP. (Source: Transplantation Reviews)
Source: Transplantation Reviews - April 14, 2016 Category: Transplant Surgery Authors: A.S. Barbas, N. Goldaracena, M.J. Dib, M. Selzner Source Type: research
Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations
Cytomegalovirus (CMV) infection remains a major complication of solid organ transplantation. Because of management of CMV is variable among transplant centers, in 2011 the Spanish Transplantation Infection Study Group (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) developed consensus guidelines for the prevention and treatment of CMV infection in solid organ transplant recipients. Since then, new publications have clarified or questioned the aspects covered in the previous document. (Source: Transplantation Reviews)
Source: Transplantation Reviews - April 14, 2016 Category: Transplant Surgery Authors: J. Torre-Cisneros, J.M. Aguado, J.J. Caston, L. Almenar, A. Alonso, S. Cantis án, J. Carratalá, C. Cervera, E. Cordero, M.C. Fariñas, M. Fernández-Ruiz, J. Fortún, E. Frauca, J. Gavaldá, D. Hernández, I. Herrero, O. Len, F. Lopez-Medrano, N. Manito Source Type: research
